Andy Wang Partner
Shanghai
021-58785888
xinwang@dentons.cn
  • Criminal Law
  • Corporate and M&A
  • Compliance and Risk Management
  • IP and Technology Innovation
  • Working Language:
  • Chinese
  • English

Introduction

Andy Wang specializes in industries such as life sciences, manufacturing, and consumer goods. His focus areas include investment transactions, industry regulations, compliance, and personal information protection within these sectors. Additionally, he excels as a dispute resolution lawyer, adept at handling complex commercial disputes. He has successfully achieved client objectives in commercial arbitration, civil litigation, and administrative litigation on numerous occasions. Fluent in English, he has consistently used it as a working language to provide services for multinational corporations and domestic clients engaged in cross-border business. Prior to joining Dacheng, he served as an associate at Pinsent Masons LLP's Shanghai Office and was also long-term seconded to Siemens to provide legal services. In recent years, Andy has been repeatedly recognized by reputable rating agencies as a recommended lawyer in healthcare or life sciences sectors.

Education

  • East China University of Political Science and LawBachelor(2020)

Admissions and Qualifications

  • PRC Licensed Lawyer
  • Legal Professional Qualification Certificate

Working Experience

  • Dacheng ShanghaiPartner(2012 ~ Present)
  • Boss & Young Law Firm (seconded counsel at Siemens China)Lawyer(2011 ~ 2012)
  • Pinsent Masons LLPAssociate(2007 ~ 2011)
  • Ingersoll RandRegional counsel for China(2005 ~ 2007)
  • Allen & John Law FirmLawyer(2000 ~ 2005)

Honors and Awards

  • Healthcare Band 3 Ranked Lawyer(2025), Chambers and Partners
  • Life Sciences and Healthcare Recommended Lawyer(2025), Legal500
  • Healthcare and Life Sciences Recommended Lawyer(2025), •LegalBand

Representative Projects/Matters

Advised Siemens Healthineers on the Shanghai proton & heavy ion project

Advised Danaher on its investments in life sciences and diagnostics sectors in China

Advised Fresenius on divestment projects

Advised Sanofi on certain business models and prepared documentations

Advised Virbac on daily operation

Advised Johnson & Johnson on multiple cybersecurity and data security projects, including the design and implementation of compliance frameworks, and developed a standard operating procedure (SOP) for conducting data due diligence exercises.

Advised Sika on its investment and divestment projects in China

Represented a number of MNCs e.g. Danaher, Siemens Healthineers, Fresenius, Sika in contentious matters

What can we do for you ?

Contact Us +